Januvia 100 mg Norveška - norveški - Statens legemiddelverk

januvia 100 mg

farmagon - sitagliptinfosfatmonohydrat - tablett, filmdrasjert - 100 mg

Rimactan 150 mg Norveška - norveški - Statens legemiddelverk

rimactan 150 mg

sandoz gmbh - rifampicin - kapsel, hard - 150 mg

Rimactan 300 mg Norveška - norveški - Statens legemiddelverk

rimactan 300 mg

sandoz gmbh - rifampicin - kapsel, hard - 300 mg

Rimactan 300 mg Norveška - norveški - Statens legemiddelverk

rimactan 300 mg

2care4 aps - rifampicin - kapsel, hard - 300 mg

Thallous (201TI) Chloride 37 MBq/ ml Norveška - norveški - Statens legemiddelverk

thallous (201ti) chloride 37 mbq/ ml

curium netherlands b.v. - talliumklorid (201tl) - injeksjonsvæske, oppløsning - 37 mbq/ ml

Milnocor 1 mg/ ml Norveška - norveški - Statens legemiddelverk

milnocor 1 mg/ ml

macure pharma aps - milrinon - injeksjons-/infusjonsvæske, oppløsning - 1 mg/ ml

Rimactan 300 mg Norveška - norveški - Statens legemiddelverk

rimactan 300 mg

orifarm as - rifampicin - kapsel, hard - 300 mg

Ryeqo Europska Unija - norveški - EMA (European Medicines Agency)

ryeqo

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyomer - hypofysiske og hypotalamiske hormoner og analoger - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.

Ryeqo Norveška - norveški - Statens legemiddelverk

ryeqo

2care4 aps - relugoliks / Østradiolhemihydrat / noretisteronacetat - tablett, filmdrasjert - 40 mg / 1 mg / 0.5 mg

Ryeqo Norveška - norveški - Statens legemiddelverk

ryeqo

orifarm as - relugoliks / Østradiolhemihydrat / noretisteronacetat - tablett, filmdrasjert - 40 mg / 1 mg / 0.5 mg